The Pediatric infectious disease journal
-
Pediatr. Infect. Dis. J. · May 2007
Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants.
The pharmacokinetics of valganciclovir were studied in 8 infants ranging in age from 4 to 90 days (mean 20 days). We suggest that doses of 15 mg/kg given twice daily may be suitable for neonates and young infants.
-
Pediatr. Infect. Dis. J. · May 2007
Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
The purpose of this study was to describe hospital use patterns of children with sickle cell disease (SCD) and human immunodeficiency virus type-1 (HIV) infection in the United States. ⋯ Hospitalized children with SCD and HIV infection have higher odds of infection than those with SCD alone. Their inpatient case-fatality rate is lower than that of children with HIV infection alone. These findings should be considered in designing appropriate interventions for this population.